OAG - OPEN-ANGLE GLAUCOMA
Clinical trials for OAG - OPEN-ANGLE GLAUCOMA explained in plain language.
Never miss a new study
Get alerted when new OAG - OPEN-ANGLE GLAUCOMA trials appear
Sign up with your email to follow new studies for OAG - OPEN-ANGLE GLAUCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye drop aims to tame silent thief of sight
Disease control Recruiting nowThis study is testing a new, preservative-free eye drop called QLS-111-FDC to see if it safely lowers eye pressure in people with open-angle glaucoma or ocular hypertension. It will compare the new drop to a standard treatment (latanoprost) over 14 days. The main goal is to see h…
Matched conditions: OAG - OPEN-ANGLE GLAUCOMA
Phase: PHASE2, PHASE3 • Sponsor: Qlaris Bio, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New device tested to fight glaucoma during cataract surgery
Disease control Recruiting nowThis is the first human trial to test the safety and effectiveness of a new surgical device for people with open-angle glaucoma who are also having cataract surgery. The device aims to improve fluid drainage in the eye to lower internal eye pressure. The study will enroll 70 part…
Matched conditions: OAG - OPEN-ANGLE GLAUCOMA
Phase: NA • Sponsor: New World Medical, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC